Imagine a world where biology has its own “periodic table of elements”—a comprehensive, shared framework that every researcher can build upon. That’s the foundational vision driving Mark Zuckerberg and Priscilla Chan’s decade-long philanthropic journey through the Chan Zuckerberg Initiative (CZI) and its Biohub network. Frustrated by the traditional model of small, incremental grants and isolated academic labs, they shifted focus from simply funding science to building the fundamental tools and shared infrastructure they believe are necessary to truly accelerate progress. Their bet is that creating open-source platforms, massive standardized datasets, and AI-powered virtual models will provide the leverage needed to cure, prevent, or manage all diseases by the end of the century.

A pivotal, and somewhat accidental, success in this strategy is the “Cell by Gene” atlas. What began as a simple annotation tool to help a few labs manage their single-cell data evolved into a global standard. Because researchers adopted the tool for its utility, they inherently standardized their data formats, leading to a community-driven repository containing millions of cells. This created a powerful network effect: 75% of the data now comes from the broader scientific community, not CZI itself. It proved that providing elegant, usable tools can organically solve the long-standing problem of incompatible biological data.

The conversation then centers on the next frontier: virtual cell models. These AI simulations, trained on the vast datasets CZI helps curate, aim to let scientists test high-risk biological hypotheses in silico before costly and time-consuming wet lab work. The goal isn’t a perfect, all-knowing model, but a useful one that provides directional signals—a “model organism” for the digital age. This approach could fundamentally change the risk calculus of research, allowing scientists to explore ideas that would be too expensive or uncertain to pursue under traditional grant systems.

Finally, they detail the operational evolution of their work into a unified “Biohub” model. The key insight is that frontier biology and frontier AI must be developed shoulder-to-shoulder. By colocating biologists, engineers, and AI researchers and giving them shared access to massive compute resources and custom-built scientific instruments, they aim to create a tight feedback loop. The models reveal what new data is needed, and the labs generate that precise data to improve the models, accelerating toward increasingly accurate and general virtual cells. This integrated, tool-building philanthropy fills a unique niche they feel is otherwise empty in the scientific ecosystem.

Surprising Insights

• Accidental Standardization: Their flagship “Cell by Gene” atlas, now a community standard, began purely as an internal tool to solve a data annotation bottleneck for a few grant recipients. The standardization was a side effect of building something useful.
• The AI-Biology Ambition Gap: When CZI first announced its century goal, traditional biologists saw it as laughably ambitious, while leading AI researchers dismissed it as boring and inevitable—highlighting a vast cultural and expectation gap between the fields.
• The “Founder-Market Fit” of Philanthropy: Zuckerberg and Chan explicitly evaluate their philanthropic work with a venture capital mindset, asking, “If we didn’t exist, would it be a problem?” They believe their unique blend of engineering, AI, and medical science makes them uniquely positioned to build these foundational tools.
• Domain-Specific AI Triumphs: Contrary to early AI narratives about a single, general super-intelligence, their experience underscores that the most powerful biological models will be specialized and hierarchical, built from protein-level data up to cellular systems.

Practical Takeaways

• Build Tools, Not Just Projects: If you want to accelerate an entire field, invest in creating open, user-friendly tools and shared infrastructure that lower barriers to entry and collaboration, rather than only funding discrete research projects.
• De-risk Innovation with Simulation: Use computational models to simulate and test ideas before committing extensive physical resources. Even an imperfect model can provide valuable directional guidance and allow for riskier, more innovative exploration.
• Force Collision for Collaboration: Break down disciplinary silos by physically colocating experts from different fields (e.g., biologists, engineers, AI researchers). Simple proximity can solve communication overhead and spark integrated solutions that org charts cannot.
• Seek Feedback from “Customers”: Even in philanthropy, you have users. Pay close attention to how and whether your tools are adopted by the community you intend to serve—their usage is the clearest signal of value and impact.
• Embrace a “Portfolio” Mindset: View the scientific ecosystem as a portfolio. Identify and support the most underrepresented yet high-leverage areas, such as long-term tool development, which traditional grant systems often fail to fund adequately.